dihexa hgf c-met cancer risk HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence c-MET: A Key Target in
c MET: A Key Target in Cancer Therapy Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease Dihexa targets neurotrophic factors like BDNF and NGF, which drive brain repair. By activating the c MET receptor, it helps cells take in nutrients and rebuildespecially in cases where recovery is dihexa hgf c met cancer risk HGF c MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Growth HGF and MET: From Brain Development to Neurological Disorders PMC Activated HGF c Met Axis in Head and Neck Cancer
Pay in 4 interest-free payments of $5.77 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




